Visna virus inoculation of mice before immunization with unrelated antigens caused suppression of humoral and cell-mediated immune responses. The immunosuppressive effect was dependent on the virus dose and time of administration. The number of "background" antibody-producing spleen cells increased slightly after inoculation of Visna virus. Mice. When not otherwise specified, Swiss albino mice (own laboratory strain) were used. In addition, mice of the strain DBA/1J were employed. Because the antibody response was found to vary considerably, depending on the animals used, only mice of the same sex and age were inoculated in each separate experiment. Visna virus was inoculated intraperitoneally, and immunization with sheep erythrocytes (SRBC) was performed by intravenous inoculation.
Visna virus has been reported to be associated with increased incidence of mammary tumors in mice (10) . However, inoculation of mice with Visna virus appeared to stimulate tumor formation only indirectly, although Visna virus belongs to the retrovirus group mainly consisting of oncogenic viruses. Several retroviruses have been reported to possess immunosuppressive properties (6) . The possibility that the increased incidence of tumors observed in Visna virusinoculated mice could be related to virus-induced immunosuppression was considered.
Several observations on the pathogenesis and histology of Visna virus infection in sheep suggest that immunopathological processes are involved (12, 15) . In the present study the effect of Visna virus on development of humoral and cellmediated immunity in mice is studied.
MATERIALS AND METHODS Cells. Sheep choroid plexus cells were cultured by a previously published method (16) with a few modifications. The choroid plexus was removed from the brain of 6-to 12-month-old sheep. The plexus was minced by scissors, trypsinized (0.25% solution), and suspended in growth medium consisting of Eagle minimal essential medium with 10% fetal calf serum (Grand Island Biological Co., Bio Cult, Glasgow, Scotland) and 0.3% glucose. The suspension was distributed in 200-ml glass flasks and incubated for 2 to 3 days. The medium was then changed to 15 ml of fresh growth medium. The medium was replaced every 3 to 4 days until confluent monolayers were formed. Subcultures were then made as previously described.
Virus. The K 796 strain of Visna virus (kindly supplied by Margret Gudnadottir, University of Reykjavik, Iceland) was propagated in confluent sheep chorid plexus cell cultures maintained in growth medium with 1% fetal calf serum. All batches of virus were titrated in tube cultures of sheep chorid-plexus, which were incubated in a roller drum for 2 weeks before the titer was read. Visna virus suspensions with titers of ca. 1065 50% infective doses (ID50) per 0.1 ml were used in all experiments. A suspension of purified Visna virus was prepared by the method of Lin and Thormar (9) . The concentration of infective virus was adjusted to 1065 ID50 per 0.1 ml.
Mice. When not otherwise specified, Swiss albino mice (own laboratory strain) were used. In addition, mice of the strain DBA/1J were employed. Because the antibody response was found to vary considerably, depending on the animals used, only mice of the same sex and age were inoculated in each separate experiment. Visna virus was inoculated intraperitoneally, and immunization with sheep erythrocytes (SRBC) was performed by intravenous inoculation.
Preparation of spleen cells. Spleen cells were obtained from 4-to 6-week-old mice that had been killed by cervical spine dislocation. The spleens were removed aseptically, and cell suspensions were prepared by squeezing the organs through a stainless steel grid into Eagle minimal essential medium. The resulting cell suspensions were transferred to tubes and allowed to sediment for 5 to 10 min. After transferring the supernatant to new tubes, we counted the cells in a hemocytometer and adjusted them to the desired density.
Determination of PFC. The hemolytic plaque method described by Cunningham 
RESULTS
Effect of Visna virus inoculation on antibody response to SRBC. Albino mice were inoculated with crude Visna virus and 5 days later immunized with 108 SRBC. After another 5 days, direct and indirect PFC were assayed. The experiment was repeated with a suspension of purified Visna virus. In both cases, a pronounced suppression of direct as well as indirect PFC was observed (Fig. 1) . The suppressive effect increased with falling concentration of virus inoculated, and maximal suppression occurred with a virus dilution of lo-4. When the virus was diluted to 10-6 or more, the suppressive effect gradually disappeared. No suppressive effect could be observed when undiluted virus was used as an inoculum. However, it is probable that a slight suppression resulted also when undiluted virus was inoculated. Thus, if the results were expressed in terms of PFC relative to number of spleen cells instead of per spleen, about a 15% suppression (P < 0.05) was detected.
To study the effect of Visna virus on secondary antibody response, mice were challenged with SRBC 28 days after initial inoculation.
Direct and indirect PFC were determined 5 days after the second injection. Under these experimental conditions, direct PFC response was significantly suppressed (P < 0.05), whereas no statistically significant suppression of indirect PFC response was observed ( Table 1) .
Influence of varying the time interval between Visna virus inoculation and SRBC administration. Visna (Fig. 2) . This inhibition was most pronounced if 15 days elapsed between the virus inoculation and SRBC injections. With 30 days or more between the inoculation virus and SRBC injection, the inhibitory effect on the immune response disappeared. However, if the virus was administered after the SRBC, a marked enhancement was observed. Thus, inhibition, as well as enhancement, was demonstrable, and the outcome seemed dependent on the timing of Visna virus inoculation relative to the injection of immunizing antigen.
Abolishment of virus-induced suppression by heat treatment of Visna virus. Visna virus suspensions were heated for 30 min at 24, 45, or 56°C. Subsequently, the suspensions were inoculated into mice, which 5 days later received 108 SRBC. Figure 3 demonstrates that heating the material at 56°C completely abolished the immunosuppressive capacity of the virus (P < 0.05). Likewise, inactivation of Visna virus with ultraviolet light significantly reduced the immunomodulating ability.
"Background" PFC in Visna virus-inoculated mice. Groups of 10 0, 7, and 14 days postinoculation. The mean PFC per spleen determined on 12 control groups was 78 ± 16. For each group of virus-inoculated mice, the mean PFC was calculated. PFC means were used to estimate ratios between results with virus inoculated and corresponding Hanks BSSinjected animals. The ratios ranged from 0.97 to 2.41. The 14-day values indicated slightly increased background activities (P < 0.05), but the Visna virus inoculation did not otherwise influence the number of PFC in the nonimmunized animals.
Effect of Visna virus inoculation on development of contact sensitivity to picryl chloride. Visna virus was injected into DBA/1J mice that were sensitized with picryl chloride. The time interval between virus inoculation and picryl chloride sensitization was varied: virus was inoculated 4, 3, or 2 weeks before picrylchloride sensitization. The mice were challenged by painting picryl chloride on the ears 5 days after sensitization. The effect of challenge was measured by determining the increment of ear thickness (Table 2) . When virus was inoculated 2 weeks before sensitization, a statistically significant (P < 0.01) suppressive effect was obtained. No significant effect was observed when virus was inoculated 3 Three days after virus inoculation, mouse thymus cell cultures were prepared. The cultures were incubated for 3 days with or without conconavalin A. Subsequently, the culture medium was replaced by ['4C]thymidine-labeled medium. Figure 4 demonstrates that the cellular response was dependent on the concentration of virus inoculated. Virus diluted 10-1 had a significant suppressive effect on mitogen-induced deoxyribonucleic acid synthesis (P < 0.01), whereas virus diluted 10-3 seemed to cause an enhancement (P < 0.05). Again, the immune response seemed dependent upon the concentration of virus inoculated. In addition, Visna virus suppressed the concanavalin A response irrespective of whether the mitogenic stimulation was performed 1, 7, or 13 days after virus inoculation.
Experiments performed on spleen cell suspensions gave similar but less reproducible results as those described above for thymus cells. High doses of Visna virus were suppressive, and low doses were stimulatory.
Interferon. A series of experiments were performed to evaluate the role of interferon on immune reactivity of Visna virus-inoculated mice. Groups of mice inoculated with Visna virus (6.5 to 3.5 log ID5o) were bled at various times (0 to 14 days) postinfection. Interferon activity in serum samples was estimated by using a reference batch of mouse interferon of known concentration. A 50% reduction of vesicular stomatitis virus replication was obtained with 3 units of the reference interferon. In no instances did the serum samples contain demonstrable interferon activity. The samples required dilution (18) . Morphological transformation of human cells by Visna virus has also been observed (11) . Inoculation of Visna virus into newborn Swiss albino mice resulted in an increased incidence of mammary carcinoma (10) . In contrast, no increased incidence of tumors was observed in strains of mice with low incidence of spontaneously developed tumors. Therefore, Visna virus itself was not considered directly responsible for the oncogenic effects observed.
A possible explanation for the increased incidence of tumors after Visna virus inoculation might be virus-induced alterations in the immune system. Induction of immunopathological processes in Visna virus-infected sheep has been observed (12, 15) .
A common characteristic of oncogenic retroviruses seems to be their ability to cause immune VOL. 20, 1978 on October 18, 2017 by guest http://iai.asm.org/ Downloaded from suppression (7) . The present results demonstrate that this property is also shared by Visna virus. Thus, both humoral and cell-mediated immunity to unrelated antigens were impaired in Visna virus-inoculated animals. Suppression of humoral and cell-mediated immunity was observed when Visna virus was inoculated before antigenic stimulation but not if the virus was administrated simultaneously with, or after, the antigen. This finding agrees with what has been described for murine leukemia viruses (7) .
The enhancement of immune reactivity observed when Visna virus was given after the antigenic stimulation is similar to observations made after infections in mice with lactic dehydrogenase virus, Venezuelan equine encephalitis virus, and mouse pneumonia virus (4, 13; M. Padnos, N. Molomut, and R. Hofer, Fed. Proc., p. 430, 1969). Several explanations have been suggested for virus-induced immunoenhancement, e.g., adjuvant activity of viral nucleic acid (2), stimulation of macrophage activity (14) increment in antibody-producing cells (14) , and viral destruction of suppressor cells (14 Brodeur and Merigan (3) reported that interferon injected before antigenic stimulation had a suppressive effect on antibody response to SRBC in mice, whereas interferon given after the antigen resulted in an enhancement. The modifications of humoral immune response to SRBC in mice evoked by mouse hepatitis virus are considered to be mediated by interferon (19) . However, we were unable to demonstrate that the Visna virus inoculation induced interferon in the mice. Moreover, interferon possibly produced in sheep charid plexus cultures and present in the virus suspensions inoculated did not display any activity in the mouse cell system. No differences in the immunomodulating effects between crude and purified Visna virus suspensions were discernible. Therefore, interferon or other soluble substances did not seem to play any significant role in the altered immune reactivity observed after Visna virus inoculation.
